BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
301301 Yili Chuanning Biotechnology
- 14.02
- +2.34+20.03%
Market Closed May 15 15:00 CST
31.22BMarket Cap23.37P/E (TTM)
14.02High11.96Low1.48MlotVolume12.01Open11.68Pre Close1.99BTurnover23.97%Turnover Ratio22.29P/E (Static)2.23BShares16.5852wk High3.81P/B8.63BFloat Cap10.4152wk Low14.02Limit Up615.89MShs Float18.11Historical High9.34Limit Down17.64%Amplitude6.72Historical Low0.23Dividend TTM13.46Avg Price789.12KlotAsk1.60%Div YieldTTM100Lot Size632.45KlotBid
Yili Chuanning Biotechnology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -14.85%1.3B | 19.38%5.76B | 24.43%4.46B | 32.20%3.2B | 19.96%1.52B | 26.24%4.82B | 21.83%3.58B | 21.84%2.42B | 27.34%1.27B | 18.21%3.82B |
| Operating revenue | -14.85%1.3B | 19.38%5.76B | 24.43%4.46B | 32.20%3.2B | 19.96%1.52B | 26.24%4.82B | 21.83%3.58B | 21.84%2.42B | 27.34%1.27B | 18.21%3.82B |
| Other operating revenue | ---- | 17.19%361.61M | ---- | 10.06%180.27M | ---- | 25.07%308.58M | ---- | 27.61%163.8M | ---- | 39.33%246.72M |
| Interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Commission income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Premiums earned | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Total operating cost | -13.75%947.59M | 11.26%4.06B | 13.95%3.15B | 18.97%2.26B | 5.55%1.1B | 12.55%3.65B | 11.77%2.77B | 13.17%1.9B | 18.70%1.04B | 7.88%3.24B |
| Operating cost | -18.64%812.76M | 10.99%3.66B | 13.97%2.86B | 19.43%2.07B | 6.54%998.93M | 14.87%3.3B | 18.97%2.51B | 22.11%1.73B | 28.21%937.61M | 14.28%2.87B |
| Operating tax surcharges | 9.54%21.6M | 19.59%79.7M | 24.66%67.5M | 24.55%46.43M | 0.15%19.72M | 21.31%66.65M | 20.17%54.14M | 24.89%37.28M | 25.43%19.69M | 37.32%54.94M |
| Operating expense | 106.68%7.95M | 13.16%25.54M | 33.78%19.57M | 31.13%11.6M | -18.95%3.85M | 96.96%22.57M | 75.56%14.63M | 37.99%8.84M | 24.24%4.75M | 17.05%11.46M |
| Administration expense | 22.95%57.53M | 15.52%165.34M | 12.92%120.91M | 12.33%82.49M | 13.95%46.79M | -0.66%143.13M | -45.84%107.07M | -49.39%73.44M | -47.51%41.06M | -37.53%144.08M |
| Financial expense | -39.50%7.66M | -20.51%48.36M | -3.82%42.46M | -4.63%27.71M | -47.17%12.67M | -50.55%60.83M | -51.00%44.15M | -54.83%29.05M | -35.45%23.98M | -30.80%123.01M |
| -Interest expense (Financial expense) | -29.85%10.82M | -29.47%61.91M | -45.02%35.27M | -46.24%25.56M | -44.06%15.43M | -38.33%87.78M | -40.18%64.15M | -36.59%47.54M | -26.22%27.58M | -19.61%142.34M |
| -Interest Income (Financial expense) | 2.61%-1.71M | 54.38%-7.38M | 55.38%-5.58M | 53.53%-3.89M | 67.01%-1.76M | -210.78%-16.18M | -221.62%-12.51M | -225.10%-8.38M | -361.64%-5.33M | 11.17%-5.21M |
| Research and development | 140.34%40.09M | 40.67%77.73M | 12.82%44.07M | 22.10%28.78M | 21.11%16.68M | 56.18%55.26M | 47.89%39.06M | 28.08%23.57M | 29.36%13.77M | 7.37%35.38M |
| Credit Impairment Loss | -353.17%-1.9M | 202.82%6.69M | 1,182.16%2.33M | 326.69%258.72K | 493.65%750.54K | 54.41%-6.5M | 101.19%181.77K | 100.39%60.64K | -118.87%-190.66K | -988.56%-14.26M |
| Asset Impairment Loss | ---- | 59.97%-17.07M | 73.25%-8.45M | 73.25%-8.45M | ---- | -157.62%-42.65M | -148.09%-31.61M | -292.08%-31.61M | -359.97%-14.72M | -30.99%-16.56M |
| Other net revenue | 394.39%3.98M | 79.68%-10.79M | 80.52%-7.06M | 69.91%-11.68M | 91.36%-1.35M | -58.72%-53.11M | -24.96%-36.22M | -73.43%-38.82M | -4,399.58%-15.63M | -966.33%-33.46M |
| Fair value change income | --0 | 102.66%31.5K | 135.44%644.5K | 95.84%-224.6K | 76.75%-519.93K | -1,938.52%-1.18M | 56.61%-1.82M | -142.10%-5.39M | -208.63%-2.24M | -110.59%-58.08K |
| Invest income | 94.75%-160.91K | 32.14%-9.2M | 38.19%-7.16M | 15.38%-6.31M | -325.42%-3.07M | -52.22%-13.55M | -1,825.75%-11.58M | -1,220.31%-7.46M | -156.02%-720.58K | -366.76%-8.9M |
| -Including: Investment income associates | -1,594.98%-659.19K | -435.46%-779.32K | -245.18%-365.35K | -69.19%-105.56K | -43.39%-38.89K | -105.78%-145.54K | -1,341.17%-105.85K | ---62.39K | ---27.12K | ---70.73K |
| Asset deal income | ---- | ---- | --0 | --0 | ---- | --1.34M | --1.34M | --1.34M | ---- | ---- |
| Other revenue | 306.85%6.04M | -7.24%8.76M | -23.17%5.58M | -28.11%3.05M | -33.61%1.48M | 49.45%9.45M | 92.04%7.27M | 50.02%4.24M | 74.45%2.24M | 68.56%6.32M |
| Operating profit | -16.51%353.33M | 50.51%1.69B | 66.69%1.29B | 93.47%919.68M | 98.48%423.23M | 105.72%1.12B | 79.07%776.74M | 69.82%475.36M | 77.89%213.24M | 143.77%545.12M |
| Add:Non operating Income | -90.21%4.44K | -44.30%1.1M | 462.05%1.07M | -61.40%67.37K | 35.31%45.4K | 5,650.76%1.98M | 333.53%190.85K | 582.04%174.54K | 48.68%33.55K | -91.96%34.43K |
| Less:Non operating expense | 146.33%3.33M | 142.99%13.77M | 114.25%17.87M | 83.51%10.59M | -53.11%1.35M | -90.15%5.67M | -81.05%8.34M | 323.11%5.77M | 197.20%2.89M | -36.06%57.52M |
| Total profit | -17.05%350M | 49.87%1.68B | 66.27%1.28B | 93.54%909.16M | 100.55%421.92M | 129.21%1.12B | 97.17%768.59M | 68.63%469.76M | 76.91%210.39M | 263.68%487.63M |
| Less:Income tax cost | -10.82%61.8M | 55.09%274.74M | 57.24%201.97M | 81.04%142.83M | 98.33%69.29M | 132.74%177.15M | 123.30%128.44M | 90.43%78.89M | 90.66%34.94M | 234.80%76.11M |
| Net profit | -18.27%288.21M | 48.88%1.4B | 68.08%1.08B | 96.06%766.33M | 100.99%352.63M | 128.56%940.56M | 92.65%640.15M | 64.82%390.87M | 74.41%175.45M | 269.58%411.52M |
| Net profit from continuing operation | -18.27%288.21M | 48.88%1.4B | 68.08%1.08B | 96.06%766.33M | 100.99%352.63M | 128.56%940.56M | 92.65%640.15M | 64.82%390.87M | 74.41%175.45M | 269.58%411.52M |
| Net income from discontinuing operating | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Minority Profit | -206.22%-11.94K | 2,514.97%26.09K | 20,523.50%38.55K | 21,386,700.00%23.53K | 936,558.33%11.24K | 250.67%997.72 | 72.73%-188.74 | 99.98%-0.11 | 99.41%-1.2 | -258.09%-662.19 |
| Net profit of parent company owners | -18.26%288.22M | 48.88%1.4B | 68.07%1.08B | 96.05%766.3M | 100.98%352.61M | 128.56%940.56M | 92.65%640.15M | 64.82%390.87M | 74.41%175.45M | 269.58%411.52M |
| Earning per share | ||||||||||
| Basic earning per share | -18.75%0.13 | 50.00%0.63 | 65.52%0.48 | 88.89%0.34 | 100.00%0.16 | 100.00%0.42 | 70.59%0.29 | 50.00%0.18 | 60.00%0.08 | 250.00%0.21 |
| Diluted earning per share | -18.75%0.13 | 50.00%0.63 | 65.52%0.48 | 88.89%0.34 | 100.00%0.16 | 100.00%0.42 | 70.59%0.29 | 50.00%0.18 | 60.00%0.08 | 250.00%0.21 |
| Other composite income | -99.34K | 0 | ||||||||
| Other composite income of parent company owners | ---- | ---99.34K | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Total composite income | -18.27%288.21M | 48.87%1.4B | 68.08%1.08B | 96.06%766.33M | 100.99%352.63M | 128.56%940.56M | 92.65%640.15M | 64.82%390.87M | 74.41%175.45M | 269.58%411.52M |
| Total composite income of parent company owners | -18.26%288.22M | 48.87%1.4B | 68.07%1.08B | 96.05%766.3M | 100.98%352.61M | 128.56%940.56M | 92.65%640.15M | 64.82%390.87M | 74.41%175.45M | 269.58%411.52M |
| Total composite income of minority owners | -206.22%-11.94K | 2,514.97%26.09K | 20,523.50%38.55K | 21,386,700.00%23.53K | 936,558.33%11.24K | 250.67%997.72 | 72.73%-188.74 | 99.98%-0.11 | 99.41%-1.2 | -258.09%-662.19 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.